98%
921
2 minutes
20
Background: Aberrant decision-making is a hallmark of substance use disorders (SUDs), often impeding recovery. While uncertainty, comprising risk and ambiguity, is central to real-world choices, its distinct effects in SUDs remain underexplored. This study disentangles risk and ambiguity to identify context-specific impairments in methamphetamine (MUD) and alcohol use disorders (AUD).
Methods: We used a Choice under Risk and Ambiguity (CRA) task to examine uncertainty decision-making (UDM) in 101 individuals with MUD, 56 with AUD, and their respective healthy control groups (HCs; n = 45 and n = 75). Group-level analyses applied a modified psychometric function to estimate decision parameters, while individual-level UDM indicators were derived using custom computational methods and subjective value models.
Results: Individuals with MUD exhibited heightened reward sensitivity and a stronger preference for large rewards under high uncertainty, with flexible shifts across ambiguity levels. Besides, reward sensitivity under high ambiguity was linked to symptom severity. In contrast, individuals with AUD showed no evident decision-making impairments across conditions and, like HCs, adopted conservative strategies under ambiguity. Direct comparisons confirmed more pronounced UDM impairments in MUD than in AUD.
Conclusion: These findings underscore the heterogeneity of decision-making patterns across SUDs, validating the need for precision in therapeutic strategies.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.bpsc.2025.08.008 | DOI Listing |
Parkinsonism Relat Disord
September 2025
Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China. Electronic address:
Background: Several studies have indicated a potential link between immune cells and Parkinson's disease (PD). However, the precise causal relationship between them, along with the ambiguous mediatory function of metabolites in this connection, remains largely undefined.
Methods: Immune cells, metabolites, and PD have been identified through extensive analysis of summary data from large-scale genome-wide association studies (GWAS).
Ann Nucl Med
September 2025
Department of Nuclear Medicine, Marmara University School of Medicine, Istanbul, Turkey.
Objective: This study aims to systematically evaluate the inter- and intra-observer agreement regarding lesions with uncertain malignancy potential in Ga-68 PSMA PET/CT imaging of prostate cancer patients, utilizing the PSMA-RADS 2.0 classification system, and to emphasize the malignancy evidence associated with these lesions.
Methods: We retrospectively reviewed Ga-68 PSMA PET/CT images of patients diagnosed with prostate cancer via histopathology between December 2016 and November 2023.
Background: Addictive disorders remain a global problem, affecting health, society and the economy. The etiopathogenesis of addictions, which have a multifactorial nature, is poorly understood, making it difficult to develop personalized treatment approaches. Of particular interest is the gene, which regulates serotonergic transmission.
View Article and Find Full Text PDFJ Genet Couns
October 2025
Department of Communication, University of Utah, Salt Lake City, Utah, USA.
With advances in next-generation sequencing technologies, individuals can seek genetic risk information for multiple conditions. However, feasibility and communication challenges could arise if offering multiple genetic tests simultaneously, such as cancer predisposition testing and carrier screening for pregnancy planning. Genetic screening introduces uncertainty from probabilistic results, ambiguous gene-disease associations, and complex variant interpretation, intertwining with psychosocial concerns impacting decision-making and emotional well-being.
View Article and Find Full Text PDFInt J Epidemiol
August 2025
Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Spain.
Background: Coinciding with the SARS-CoV-2 pandemic, malaria cases and malaria-related deaths increased globally between 2020 and 2022. However, evidence linking the pandemic to increased malaria burden remains ambiguous. We assessed the extent to which an observed malaria resurgence in Lambaréné, Gabon, can be associated with pandemic-related disruptions in malaria control programmes.
View Article and Find Full Text PDF